Thursday, December 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

XRP Faces a Supply Crunch as Institutional Demand Soars

Felix Baarz by Felix Baarz
December 11, 2025
in Analysis, Blockchain, ETF, Ethereum & Altcoins, Trading & Momentum
0
XRP Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

At first glance, XRP appears to be struggling, trading well below its yearly peak. However, this corrective facade masks a significant underlying shift. As price action stalls, substantial movements are occurring behind the scenes: exchange-traded funds (ETFs) and major investors are rapidly draining available supply, causing exchange reserves to plummet. This stark divergence between weak technicals and powerful on-chain fundamentals suggests a major directional move is imminent.

Institutional Accumulation Reaches a Fever Pitch

The primary reason for analyst optimism, despite the lackluster price chart, is unprecedented institutional demand. Since their launch in mid-November, spot XRP ETFs have attracted capital at a pace that even surpasses the early days of Bitcoin and Ethereum ETF products.

  • Approaching $1 Billion: Net inflows are nearing the $1 billion threshold, currently standing at approximately $944 million.
  • Unbroken Inflow Streak: These funds have recorded 15 consecutive days of inflows, completely disregarding the sideways price movement.
  • Direct Market Impact: These investment vehicles alone have already absorbed more than 500 million XRP tokens from the freely traded market.

Exchange Reserves Plummet

This aggressive accumulation is triggering a dramatic contraction in readily available supply. Data from Glassnode confirms that XRP holdings on centralized exchanges have collapsed by 45% over the past two months. In the last three weeks alone, over one billion tokens have been withdrawn from trading platforms—a classic indicator that investors are moving assets into long-term storage.

A massive redistribution of tokens is occurring simultaneously. While smaller retail investors sell, large-scale holders are buying. Wallets containing between 10 million and 100 million XRP acquired holdings worth over $700 million in just four days.

Should investors sell immediately? Or is it worth buying XRP?

Technical Vulnerabilities and Support Test

From a purely technical perspective, XRP is navigating a precarious phase. The asset is currently priced at $2.05, testing a critical support band between $2.00 and $2.02. A decisive break below this level could trigger further selling pressure, especially given that annualized volatility remains elevated above 53%.

Derivatives data paints a risky picture. Funding rates have recently spiked, signaling a high concentration of leveraged bets anticipating higher prices. Should the $2.00 support fail, a “long squeeze” forcing the liquidation of these positions becomes a tangible threat. However, with a Relative Strength Index (RSI) reading of 28.8, the market is already technically oversold, which may limit the potential for further downside.

Regulatory Tailwinds and Market Outlook

The broader market environment is providing additional support. The U.S. Office of the Comptroller of the Currency (OCC) recently criticized what it called “politically motivated” account closures for crypto firms by banks, a move that strengthens the sector. Furthermore, Bitnomial has launched XRP trading, becoming the first CFTC-regulated exchange to do so.

The market structure is now clearly defined. Short-term technical risks around the $2.00 level are colliding with a fundamental supply shock. Once the current consolidation phase concludes and the market digests the upcoming U.S. Federal Reserve interest rate decision, the severe imbalance between depleted exchange inventories and relentless ETF demand is likely to dictate the next major trend.

Ad

XRP Stock: Buy or Sell?! New XRP Analysis from December 11 delivers the answer:

The latest XRP figures speak for themselves: Urgent action needed for XRP investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 11.

XRP: Buy or sell? Read more here...

Tags: XRP
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Rayonier Advanced Materials Stock
Analysis

Leadership Transition Looms for Rayonier Advanced Materials Amid Stock Surge

December 11, 2025
iShares MSCI Global Gold Miners ETF Stock
Commodities

Gold Mining ETFs Surge as Bullion Prices Reach New Heights in 2025

December 11, 2025
Assembly Biosciences Stock
Analysis

Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades

December 11, 2025
Next Post
Ballard Power Stock

Ballard Power: A Cautious Market Appraises Operational Gains

Nel ASA Stock

Nel ASA Strengthens Project Leadership Amid Strong Order Intake

Gold Stock

Gold Nears Record Territory as Central Bank Moves and Demand Converge

Recommended

Airbus Stock

Airbus Shares Weather a Crisis with Unprecedented Fleet Response

1 week ago
Healthcare Services Stock Exchange

Analyst Maintains Hold Rating on DaVita Raises Price Target

2 years ago
Finance_ projections

Block Incs Upgrade and Price Target Increase Boosts Stock Performance

2 years ago
Finance_ projections

Analysis of Stock Forecast for Various Companies on March 5 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Nio Shares Seek a Firmer Foundation After Steep Decline

Vulcan Energy Secures Full Funding and Key Site for Lithium Project

NASA Contract Bolsters Investor Confidence in Plug Power

Gold Nears Record Territory as Central Bank Moves and Demand Converge

Nel ASA Strengthens Project Leadership Amid Strong Order Intake

Ballard Power: A Cautious Market Appraises Operational Gains

Trending

Rayonier Advanced Materials Stock
Analysis

Leadership Transition Looms for Rayonier Advanced Materials Amid Stock Surge

by Dieter Jaworski
December 11, 2025
0

Rayonier Advanced Materials Inc. has announced that its Chief Executive Officer, De Lyle W. Bloomquist, intends to...

iShares MSCI Global Gold Miners ETF Stock

Gold Mining ETFs Surge as Bullion Prices Reach New Heights in 2025

December 11, 2025
Assembly Biosciences Stock

Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades

December 11, 2025
Nio Stock

Nio Shares Seek a Firmer Foundation After Steep Decline

December 11, 2025
Vulcan Energy Stock

Vulcan Energy Secures Full Funding and Key Site for Lithium Project

December 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Leadership Transition Looms for Rayonier Advanced Materials Amid Stock Surge
  • Gold Mining ETFs Surge as Bullion Prices Reach New Heights in 2025
  • Assembly Biosciences Gains Favor as Clinical Data Prompts Analyst Upgrades

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com